Israeli coronavirus treatment benefits six patients

Six moderate to severe Israeli coronavirus patients have shown clinical improvement with the new opaganib  treatment from Israel’s Redhill (see here previously). All required less supplemental oxygenation, had higher lymphocyte counts and less lung inflammation.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *